
OPK
Opko Health Inc.
$1.44
-$0.01(-0.69%)
42
Overall
55
Value
30
Tech
--
Quality
Market Cap
$1.15B
Volume
2.74M
52W Range
$1.11 - $2.04
Target Price
$2.65
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $491.7M | $1.2B | $966.0M | $990.3M | $901.9M | $1.4B | $1.8B | $1.0B | $863.5M | $713.1M | ||
Total Revenue | $491.7M | $1.2B | $966.0M | $990.3M | $901.9M | $1.4B | $1.8B | $1.0B | $863.5M | $713.1M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $235.2M | $611.5M | $-61.2M | $-58.0M | $511.2M | $894.4M | $1.2B | $716.0M | $545.4M | $-99.0M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $256.5M | $610.2M | $345.9M | $385.6M | $390.7M | $541.0M | $581.5M | $288.2M | $318.1M | $218.5M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $349.9M | $666.5M | $-1.2B | $-1.2B | $1.2B | $1.4B | $1.8B | $534.3M | $476.2M | $492.1M | ||
Research & Development | $99.5M | $111.2M | $126.4M | $125.6M | $117.9M | $75.3M | $76.8M | $73.9M | $89.6M | $105.2M | ||
Research Expense | $99.5M | $111.2M | $126.4M | $125.6M | $117.9M | $75.3M | $76.8M | $73.9M | $89.6M | $105.2M | ||
Selling, General & Administrative | $196.6M | $490.9M | $414.6M | $358.3M | $343.3M | $355.6M | $468.9M | $372.7M | $300.6M | $304.2M | ||
Selling & Marketing Expenses | -- | -- | $414.6M | $358.3M | -- | -- | -- | -- | -- | -- | ||
General & Administrative Expenses | $196.6M | $490.9M | $-18.9M | $-18.9M | $343.3M | $355.6M | $468.9M | $372.7M | $300.6M | $304.2M | ||
Salaries & Wages | $-26.1M | $-42.7M | $-28.3M | $-21.8M | $13.4M | $8.9M | $13.6M | -- | -- | -- | ||
Depreciation & Amortization | $28.0M | $64.4M | $71.5M | $67.9M | $64.8M | $56.4M | $50.3M | $87.8M | $86.0M | $82.6M | ||
Depreciation & Amortization | $28.0M | $64.4M | $71.5M | $67.9M | $64.8M | $56.4M | $50.3M | $87.8M | $86.0M | $82.6M | ||
Amortization | $28.0M | $64.4M | $71.5M | $67.9M | $64.8M | $56.4M | $50.3M | $87.8M | $86.0M | $82.6M | ||
Other Operating Expenses | $25.9M | $-1.3B | $-1.2B | $-1.2B | $-884.0K | $-441.0K | $-166.0K | $1.2B | $1.0B | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $-93.4M | $-56.3M | $-266.7M | $-166.2M | $-274.1M | $57.7M | $18.8M | $-226.3M | $-157.0M | $-152.1M | ||
EBITDA | $-101.7M | $15.6M | $-169.6M | $-79.7M | $-207.1M | $156.0M | $83.6M | $-270.0M | $-64.4M | $135.3M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | -- | -- | -- | -- | $3.1M | $21.9M | $18.9M | $12.1M | $13.5M | $47.5M | ||
Intinc | -- | -- | $-6.0M | $-10.7M | -- | -- | -- | $2.0M | $4.0M | $8.4M | ||
Net Non-Operating Interest Income/Expense | -- | -- | $-6.0M | $-10.7M | $-3.1M | $-3.0M | $-2.3M | $10.1M | $-9.5M | $-39.0M | ||
Gain on Sale of Securities | $-39.1M | $2.8M | $52.0K | $3.0M | $174.0K | $50.0K | $846.0K | $649.0K | $-781.0K | $-26.2M | ||
Other Income/Expense | $51.7M | $24.9M | $539.0K | $-21.4M | $16.1M | $5.5M | $193.0K | $-135.3M | $16.8M | $-302.2M | ||
Other Special Charges | $-434.0K | $-3.0M | $10.5M | $1.5M | $-31.1M | $-9.1M | $-33.6M | $-155.8M | $-17.0M | $206.9M | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | -- | $-9.6M | $-1.0M | $-1.2M | -- | $-2.0M | -- | -- | -- | ||
Special Income Charges | -- | -- | $-13.2M | $-21.8M | $-92.4M | -- | $-7.4M | $-2.8M | $2.3M | -- | ||
Impairment of Capital Assets | -- | -- | $13.2M | $21.8M | $92.4M | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-145.1M | $-81.2M | $-271.9M | $-177.3M | $-301.9M | $70.6M | $4.9M | $-379.8M | $-170.9M | $37.1M | ||
Pre-Tax Income | $-145.1M | $-81.2M | $-271.9M | $-177.3M | $-305.0M | $48.7M | $-14.0M | $-391.5M | $-184.3M | $-10.4M | ||
INCOME TAX | ||||||||||||
Tax Provision | $-113.7M | $-56.1M | $18.9M | $-38.7M | $7.1M | $17.6M | $15.5M | $-63.5M | $4.4M | $42.8M | ||
NET INCOME | ||||||||||||
Net Income | $-30.0M | $-25.1M | $-305.3M | $-153.0M | $-314.9M | $30.6M | $-30.1M | $-328.4M | $-188.9M | $-53.2M | ||
Net Income (Continuing Operations) | $-30.0M | $-25.1M | $-305.3M | $-153.0M | $-314.9M | $30.6M | $-30.1M | $-328.4M | $-188.9M | $-53.2M | ||
Net Income (Discontinued Operations) | $-30.0M | $-25.1M | $-305.3M | $-153.0M | $-314.9M | $30.6M | $-30.1M | $-328.4M | $-188.9M | $-53.2M | ||
Net Income (Common Stockholders) | $-30.0M | $-25.1M | $-305.3M | $-153.0M | $-314.9M | $30.6M | $-30.1M | $-328.4M | $-188.9M | $-53.2M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-131.8M | ||
TOTALS | ||||||||||||
Total Expenses | $585.2M | $1.3B | $-1.3B | $-1.2B | $1.7B | $2.2B | $2.9B | $1.3B | $1.0B | $393.1M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $488.1M | $550.8M | $559.2M | $563.1M | $595.5M | $640.7M | $648.1M | $719.1M | $751.8M | $694.0M | ||
Average Shares Outstanding (Diluted) | $488.1M | $550.8M | $559.2M | $1.2B | $595.5M | $640.7M | $648.1M | $719.1M | $751.8M | $694.0M | ||
Shares Outstanding | $545.7M | $558.2M | $559.5M | $615.6M | $669.8M | $670.0M | $681.5M | $772.7M | $697.0M | $671.6M | ||
Basic EPS | $-0.06 | $-0.05 | $-0.55 | $-0.27 | $-0.53 | $0.05 | $-0.05 | $-0.46 | $-0.25 | $-0.08 | ||
Basic EPS (Continuing Operations) | $-0.06 | $-0.05 | -- | -- | $-0.53 | $0.05 | $-0.05 | $-0.46 | $-0.25 | $-0.08 | ||
Diluted EPS | $-0.06 | $-0.04 | $-0.55 | $-0.13 | $-0.53 | $0.05 | $-0.05 | $-0.46 | $-0.25 | $-0.08 | ||
Diluted EPS (Continuing Operations) | -- | $-0.04 | -- | -- | -- | -- | $-0.05 | $-0.46 | -- | -- | ||
OTHER METRICS | ||||||||||||
Earnings from equity interest | $-7.1M | $-7.7M | $-14.5M | $-14.5M | $-62.9M | $-480.0K | $-629.0K | $-383.0K | $-107.0K | $-18.0K | ||
Earnings From Equity Interest Net Of Tax | $-7.1M | $-7.7M | $-14.5M | $-14.5M | $-62.9M | $-480.0K | $-629.0K | $-383.0K | $-107.0K | $-18.0K | ||
Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | $31.5M | $18.6M | -- | $121.5M | ||
Interest Expense Operating | -- | -- | -- | -- | -- | -- | $-8.5M | -- | -- | -- | ||
Minority Interests | $1.4M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Net Income Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | $121.5M | ||
Net Income From Other Gains Losses | -- | -- | -- | $-14.5M | $-2.9M | $-480.0K | -- | -- | -- | -- | ||
Other Gand A | $196.6M | $490.9M | $-18.9M | $-18.9M | $343.3M | $355.6M | $468.9M | $372.7M | $300.6M | $304.2M | ||
Other Impairment Of Capital Assets | -- | -- | $-13.2M | -- | -- | -- | -- | -- | -- | -- | ||
Rent And Landing Fees | $-7.8M | $-18.8M | $-18.9M | $-18.9M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | -- | -- | $414.6M | $358.3M | -- | -- | -- | -- | -- | -- | ||
Othspecchg | -- | -- | -- | -- | -- | -- | $9.4M | -- | -- | -- | ||
Restruct | -- | -- | $-9.6M | $-1.0M | $-1.2M | -- | $-2.0M | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | OPK | $1.44 | -0.7% | 2.74M |
3 | ||||
4 | ||||
5 | ||||
6 |